247 related articles for article (PubMed ID: 15787500)
1. aza-Prins-pinacol approach to 7-azabicyclo[2.2.1]heptanes and ring expansion to [3.2.1]tropanes.
Armstrong A; Shanahan SE
Org Lett; 2005 Mar; 7(7):1335-8. PubMed ID: 15787500
[TBL] [Abstract][Full Text] [Related]
2. Aza-Prins-pinacol approach to 7-azabicyclo[2.2.1]heptanes: syntheses of (+/-)-epibatidine and (+/-)-epiboxidine.
Armstrong A; Bhonoah Y; Shanahan SE
J Org Chem; 2007 Oct; 72(21):8019-24. PubMed ID: 17867705
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of new bridgehead substituted azabicyclo-[2.2.1]heptane and -[3.3.1]nonane derivatives as potent and selective α7 nicotinic ligands.
Slowinski F; Ben Ayad O; Vache J; Saady M; Leclerc O; Lochead A
Org Lett; 2010 Nov; 12(21):5004-7. PubMed ID: 20939603
[TBL] [Abstract][Full Text] [Related]
4. Application of intramolecular enyne metathesis to the synthesis of aza[4.2.1]bicyclics: enantiospecific total synthesis of (+)-anatoxin-a.
Brenneman JB; Martin SF
Org Lett; 2004 Apr; 6(8):1329-31. PubMed ID: 15070329
[TBL] [Abstract][Full Text] [Related]
5. 7-substituted 2-azabicyclo[2.2.1]heptanes as key intermediates for the synthesis of novel epibatidine analogues; synthesis of syn-and anti-isoepiboxidine.
Malpass JR; White R
J Org Chem; 2004 Aug; 69(16):5328-34. PubMed ID: 15287778
[TBL] [Abstract][Full Text] [Related]
6. Stereodivergent access to polyhydroxylated 10-azabicyclo[4.3.1]decanes as new calystegine analogues.
Chagnault V; Compain P; Lewinski K; Ikeda K; Asano N; Martin OR
J Org Chem; 2009 Apr; 74(8):3179-82. PubMed ID: 19298052
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of n-heteroaryl-7-azabicyclo[2.2.1]heptane derivatives via palladium-bisimidazol-2-ylidene complex catalyzed amination reactions.
Cheng J; Trudell ML
Org Lett; 2001 May; 3(9):1371-4. PubMed ID: 11348237
[TBL] [Abstract][Full Text] [Related]
8. Stereocontrolled synthesis of angularly substituted 1-azabicyclic rings by cationic 2-aza-cope rearrangements.
Aron ZD; Overman LE
Org Lett; 2005 Mar; 7(5):913-6. PubMed ID: 15727473
[TBL] [Abstract][Full Text] [Related]
9. Approaches to syn-7-substituted 2-azanorbornanes as potential nicotinic agonists; synthesis of syn- and anti-isoepibatidine.
Malpass JR; Handa S; White R
Org Lett; 2005 Jun; 7(13):2759-62. PubMed ID: 15957940
[TBL] [Abstract][Full Text] [Related]
10. Unstabilized azomethine ylides for the stereoselective synthesis of substituted piperidines, tropanes, and azabicyclo[3.1.0] systems.
Ischay MA; Takase MK; Bergman RG; Ellman JA
J Am Chem Soc; 2013 Feb; 135(7):2478-81. PubMed ID: 23398467
[TBL] [Abstract][Full Text] [Related]
11. Fluorinated conformationally restricted gamma-aminobutyric acid aminotransferase inhibitors.
Lu H; Silverman RB
J Med Chem; 2006 Dec; 49(25):7404-12. PubMed ID: 17149870
[TBL] [Abstract][Full Text] [Related]
12. Stereocontrolled synthesis of trisubstituted cyclopropanes: expedient, atom-economical, asymmetric syntheses of (+)-Bicifadine and DOV21947.
Xu F; Murry JA; Simmons B; Corley E; Fitch K; Karady S; Tschaen D
Org Lett; 2006 Aug; 8(17):3885-8. PubMed ID: 16898842
[TBL] [Abstract][Full Text] [Related]
13. Expedient approach to novel N-unprotected bicyclic azapyrimidine and pyridine structures.
Liu Z; Qin L; Zard SZ
Org Lett; 2012 Dec; 14(23):5976-9. PubMed ID: 23167272
[TBL] [Abstract][Full Text] [Related]
14. Ugi and Passerini reactions of biocatalytically derived chiral aldehydes: application to the synthesis of bicyclic pyrrolidines and of antiviral agent telaprevir.
Moni L; Banfi L; Basso A; Carcone L; Rasparini M; Riva R
J Org Chem; 2015 Apr; 80(7):3411-28. PubMed ID: 25801330
[TBL] [Abstract][Full Text] [Related]
15. Mesoionic 1,3-oxazinium olates. rearrangement to acylketenes and 3-azabicyclo[3.1.1]heptanetriones.
Sheibani H; Bernhardt PV; Wentrup C
J Org Chem; 2005 Jul; 70(15):5859-61. PubMed ID: 16018678
[TBL] [Abstract][Full Text] [Related]
16. Modification of 1-substituents in the 2-azabicyclo[2.1.1]hexane ring system; approaches to potential nicotinic acetylcholine receptor ligands from 2,4-methanoproline derivatives.
Malpass JR; Patel AB; Davies JW; Fulford SY
J Org Chem; 2003 Nov; 68(24):9348-55. PubMed ID: 14629156
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationships of 8-azabicyclo[3.2.1]octane benzylamine NK1 antagonists.
Thomson CG; Carlson E; Chicchi GG; Kulagowski JJ; Kurtz MM; Swain CJ; Tsao KL; Wheeldon A
Bioorg Med Chem Lett; 2006 Feb; 16(4):811-4. PubMed ID: 16307878
[TBL] [Abstract][Full Text] [Related]
18. Double-Mannich annulation of cyclic ketones using N,N-Bis(ethoxymethyl)alkylamine reagents.
Halliday JI; Chebib M; Turner P; McLeod MD
Org Lett; 2006 Jul; 8(15):3399-401. PubMed ID: 16836415
[TBL] [Abstract][Full Text] [Related]
19. Aza-Quaternary Scaffolds from Selective Bond Cleavage of Bridgehead-Substituted 7-Azabicyclo[2.2.1]heptane: Total Synthesis of (+)-Cylindricines C-E and (-)-Lepadiformine A.
Pandey G; Janakiram V
Chemistry; 2015 Sep; 21(37):13120-6. PubMed ID: 26220441
[TBL] [Abstract][Full Text] [Related]
20. New and efficient synthesis of azabicyclo[4.4.0]alkane amino acids by Rh-catalyzed cyclohydrocarbonylation.
Mizutani N; Chiou WH; Ojima I
Org Lett; 2002 Dec; 4(26):4575-8. PubMed ID: 12489933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
